Aibotics, Inc. SEC filings AIBT

Aibotics, Inc. has 110 filings in SEC EDGAR's recent list, going back to Jan 31, 2019. Its latest annual report, Form 10-K, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (material agreement, acquisition or sale of assets). The company's fiscal year ends on December 31.

Form Description Filed Period
10-K Annual report Apr 15, 2026 Dec 31, 2025
10-K Annual report Apr 11, 2025 Dec 31, 2024
10-K Annual report Apr 23, 2024 Dec 31, 2023
10-K/A Amended annual report Nov 6, 2023 Dec 31, 2022
10-K/A Amended annual report Oct 17, 2023 Dec 31, 2021
10-K Annual report Mar 30, 2023 Dec 31, 2022
10-K Annual report Apr 14, 2022 Dec 31, 2021
10-K Annual report Apr 15, 2021 Dec 31, 2020
10-K Annual report Mar 30, 2020 Dec 31, 2019

Showing 9 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
AIBT (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Heyburn, ID
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1763329
Former names
Mycotopia Therapies, Inc. (until Dec 17, 2024); 20/20 Global, Inc. (until May 19, 2021)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.